| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |